Zoetis said a $3.5 billion share repurchase program approved in December 2021 was completed as of December 31, 2024. The company said a maximum $6 billion program approved in August 2024 had $5.6 billion remaining as of that date.

1. 01

   Zoetis said a $3.5 billion share repurchase program approved in December 2021 was completed as of December 31, 2024. The company said a maximum $6 billion program approved in August 2024 had $5.6 billion remaining as of that date.

2. 02

   Zoetis said it repurchased 10.4 million shares for $1.8 billion in 2024. This amount does not include $17 million accrued for unpaid taxes on net share repurchases.

3. 03

   Zoetis said approximately 41% of revenue for the year ended December 31, 2024 was denominated in foreign currencies and approximately 59% was in U.S. dollars. The company also said year-over-year total revenue growth was unfavorably impacted by 3% from changes in foreign currency values.

4. 04

   The company said there were no amounts drawn under the $1.0 billion revolving credit facility, which expires in December 2027, as of both December 31, 2024 and December 31, 2023. Borrowings outstanding related to the separate $50 million lines of credit were no amounts as of the end of 2024 and $3 million as of the end of 2023.

Key figures

Fiscal year ended December 31, 2024

Revenue

$9.3B

Net income

$2.5B

EPS

$5.47

Operating cash flow

$3.0B

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.